Cargando…

Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromsø Study

OBJECTIVE: Low serum 25(OH)D levels are associated with cardiovascular risk factors, and also predict future myocardial infarction (MI), type 2 diabetes (T2DM), cancer and all-cause mortality. Recently several single nucleotide polymorphisms (SNPs) associated with serum 25-hydroxyvitamin D (25(OH)D)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorde, Rolf, Schirmer, Henrik, Wilsgaard, Tom, Joakimsen, Ragnar Martin, Mathiesen, Ellisiv Bøgeberg, Njølstad, Inger, Løchen, Maja-Lisa, Figenschau, Yngve, Berg, Jens Petter, Svartberg, Johan, Grimnes, Guri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359337/ https://www.ncbi.nlm.nih.gov/pubmed/22649517 http://dx.doi.org/10.1371/journal.pone.0037295

Ejemplares similares

The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study
por: Jorde, Rolf, et al.
Publicado: (2015)

Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
por: Zostautiene, Ieva, et al.
Publicado: (2015)

Correction: Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
por: Martinaityte, Ieva, et al.
Publicado: (2016)

Effects of Age and Sex on Estimated Diabetes Prevalence Using Different Diagnostic Criteria: The Tromsø OGTT Study
por: Hutchinson, Moira Strand, et al.
Publicado: (2013)

Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012
por: Carlsson, Maria, et al.
Publicado: (2016)

Association of occasional smoking with total mortality in the population-based Tromsø study, 2001–2015
por: Løchen, Maja-Lisa, et al.
Publicado: (2017)

Evaluation of Serum 25-Hydroxyvitamin D as a Predictor of Carotid Intima-Media Thickness and Carotid Total Plaque Area in Nonsmokers: The Tromsø Study
por: Kamycheva, Elena, et al.
Publicado: (2013)

Data from national health registers as endpoints for the Tromsø Study: Correctness and completeness of stroke diagnoses
por: Varmdal, Torunn, et al.
Publicado: (2021)

Cardiovascular health and the modifiable burden of incident myocardial infarction: the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2015)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Sex-Specific Associations between Blood Pressure and Risk of Atrial Fibrillation Subtypes in the Tromsø Study
por: Espnes, Hilde, et al.
Publicado: (2021)

Cohort profile: The Tromsø Study
por: Jacobsen, Bjarne K, et al.
Publicado: (2012)

Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2014)

Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study—the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2020)

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2020)

Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population‐Based Tromsø Study
por: Ball, Jocasta, et al.
Publicado: (2018)

Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Tromsø Study 1994–2016
por: Hopstock, Laila A, et al.
Publicado: (2018)

Validating Acute Myocardial Infarction Diagnoses in National Health Registers for Use as Endpoint in Research: The Tromsø Study
por: Varmdal, Torunn, et al.
Publicado: (2021)

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study
por: Rinde, Ludvig B., et al.
Publicado: (2016)

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2020)

Vitamin D, Insulin Secretion, Sensitivity, and Lipids: Results From a Case-Control Study and a Randomized Controlled Trial Using Hyperglycemic Clamp Technique
por: Grimnes, Guri, et al.
Publicado: (2011)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
por: Tiwari, Sweta, et al.
Publicado: (2015)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study
por: Lappegård, Jostein, et al.
Publicado: (2018)

Low Pain Tolerance Is Associated With Coronary Angiography, Coronary Artery Disease, and Mortality: The Tromsø Study
por: Fladseth, Kristina, et al.
Publicado: (2021)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)

Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study
por: Sharashova, Ekaterina, et al.
Publicado: (2020)

Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study
por: Skjelbakken, Tove, et al.
Publicado: (2014)

Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905–1977 in the population-based Tromsø Study 1979–2016
por: Hopstock, Laila Arnesdatter, et al.
Publicado: (2017)

Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts
por: Aspelund, Thor, et al.
Publicado: (2019)

Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of The Tromsø Study
por: Joseph, Josepha, et al.
Publicado: (2010)

Increased calcium intake is associated lower serum 25-hydroxyvitamin D levels in subjects with adequate vitamin D intake: a population-based observational study
por: Jorde, Rolf, et al.
Publicado: (2020)

Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994–2013
por: Norvik, Jon V., et al.
Publicado: (2017)

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study
por: Lind, Caroline, et al.
Publicado: (2017)

Associations of serum 25-hydroxyvitamin D and subjective sleep measures in an arctic population: Insights from the population-based Tromsø Study
por: Larsen, A.U., et al.
Publicado: (2022)

No significant effect on bone mineral density by high doses of vitamin D(3 )given to overweight subjects for one year
por: Jorde, Rolf, et al.
Publicado: (2010)

Data on gender contrasts in the risk of incident myocardial infarction by age. The Tromsø Study 1979–2012
por: Albrektsen, Grethe, et al.
Publicado: (2017)

Lifestyle factors as mediators of area-level socio-economic differentials in cardiovascular disease risk factors. The Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2022)

Plasma profile of microRNA after supplementation with high doses of vitamin D(3) for 12 months
por: Jorde, Rolf, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_srv69fg7aof14qpfu30g62h8nt